Showing results (2001-2010 of 3,623) with videos related to
Sort By:
Pageof 363
Drug Design and Discovery|January 1, 1993
Neuromedicinal chemistry of 5-HT1A-receptor agonists and antagonistsU Hacksell, Y Liu, H Yu, et al.IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|May 13, 2015
Software-based high-level synthesis design of FPGA beamformers for synthetic aperture imagingJoao Amaro, Billy Y S Yiu, Gabriel Falcao, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 6, 2020
Identification of a TH 2-high psoriasis cluster based on skin biomarker analysis in a Chinese psoriasis populationJ Chen, C Li, H Li, et al.Clinical Colorectal Cancer|June 15, 2015
Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas AdenocarcinomaDaneng Li, Marinela Capanu, Kenneth H Yu, et al.Immunity|May 24, 2001
GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cellsB Lu, H Yu, C Chow, et al.Chinese Medical Sciences Journal = Chung-Kuo I Hsueh K'O Hsueh Tsa Chih|May 22, 2001
Diagnosis and treatment of stage-III peripheral squamous cell carcinoma of right upper lungH Guo, Z Li, Z Zhang, et al.Journal of Molecular Biology|May 26, 1995
Mutations that stabilize folding intermediates of phage P22 tailspike protein: folding in vivo and in vitro, stability, and structural contextM Beissinger, S C Lee, S Steinbacher, et al.Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 1, 1994
[Haemorrheological effects of different processed products of radix Aconiti Kusnezoffii on animal model with syndrome of "accumulation of cold and blood stasis"]H M Bian, J Y Zhou, C Ma, et al.Cancer|March 15, 1995
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinomaM A Levesque, D Katsaros, H Yu, et al.Human Molecular Genetics|September 21, 2007
The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancyMelinda S Martin, Bin Tang, Ligia A Papale, et al.Pageof 363